Corvus Pharmaceuticals, Inc. (CRVS) stock
CRVSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$10.19+0.02 (+0.20%)
Close on Nov 18, 2026Market cap $857.19MP/E –Yield –
Corvus Pharmaceuticals free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Corvus Pharmaceuticals's free cash flow for the twelve months ending Jun 30, 2026 was -$45.23M. For fiscal 2025 it was -$32.97M. The highest annual figure on record is -$13.08M in fiscal 2015.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$32.97M | – |
| FY2023 | Dec 31, 2023 | -$23.97M | – |
| FY2022 | Dec 31, 2022 | -$27.29M | – |
| FY2021 | Dec 31, 2021 | -$36.72M | – |
| FY2020 | Dec 31, 2020 | -$34.85M | – |
| FY2019 | Dec 31, 2019 | -$37.35M | – |
| FY2018 | Dec 31, 2018 | -$41.34M | – |
| FY2017 | Dec 31, 2017 | -$46.48M | – |
| FY2016 | Dec 31, 2016 | -$30.06M | – |
| FY2015 | Dec 31, 2015 | -$13.08M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$15.98M | – |
| Q1 FY2026 | Mar 31, 2026 | -$10.47M | – |
| Q4 FY2025 | Dec 31, 2025 | -$9.22M | – |
| Q3 FY2025 | Sep 30, 2025 | -$9.57M | – |
| Q2 FY2025 | Jun 30, 2025 | -$5.89M | – |
| Q1 FY2025 | Mar 31, 2025 | -$8.30M | – |
| Q4 FY2023 | Dec 31, 2023 | -$5.17M | – |
| Q3 FY2023 | Sep 30, 2023 | -$5.43M | – |
| Q2 FY2023 | Jun 30, 2023 | -$5.22M | – |
| Q1 FY2023 | Mar 31, 2023 | -$8.15M | – |
| Q4 FY2022 | Dec 31, 2022 | -$7.55M | – |
| Q3 FY2022 | Sep 30, 2022 | -$7.19M | – |
| Q4 FY2020 | Dec 31, 2020 | -$8.21M | – |
| Q4 FY2019 | Dec 31, 2019 | -$8.52M | – |
| Q3 FY2019 | Sep 30, 2019 | -$10.61M | – |
| Q2 FY2019 | Jun 30, 2019 | -$9.21M | – |
| Q1 FY2019 | Mar 31, 2019 | -$9.01M | – |
| Q4 FY2018 | Dec 31, 2018 | -$8.39M | – |
| Q3 FY2018 | Sep 30, 2018 | -$10.96M | – |
| Q2 FY2018 | Jun 30, 2018 | -$10.94M | – |
| Q1 FY2018 | Mar 31, 2018 | -$11.05M | – |
| Q4 FY2017 | Dec 31, 2017 | -$10.97M | – |
| Q3 FY2017 | Sep 30, 2017 | -$10.82M | – |
| Q2 FY2017 | Jun 30, 2017 | -$11.83M | – |
| Q1 FY2017 | Mar 31, 2017 | -$12.86M | – |
| Q4 FY2016 | Dec 31, 2016 | -$10.02M | – |
| Q3 FY2016 | Sep 30, 2016 | -$6.78M | – |
See a number that looks wrong?